Interinstitutional Variation in Management Decisions for Treatment of 4 Common Types of Cancer
Jane C. Weeks(King Edward Memorial Hospital), Deborah Schrag(Dana-Farber Brigham Cancer Center), Nathan Taback(Ontario Institute for Cancer Research), Hajime Uno(Dana-Farber Cancer Institute), Thomas A. D’Amico(General Marble (Greece)), Jonathan W. Friedberg(University of Rochester), Angel M. Cronin, Gladys Ting(Dana-Farber Cancer Institute)
Cited by 25
Related Papers
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
|New England Journal of Medicine|2017|6k
How To Build and Interpret a Nomogram for Cancer Prognosis
|Journal of Clinical Oncology|2008|3.4k
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
|Journal of Clinical Oncology|2015|2.6k
Diagnosis and Treatment of Metastatic Colorectal Cancer
|JAMA|2021|2.6k